NH
New Hampshire State Representative

Ron Dunn

R

New Hampshire State Representative

Ron Dunn 2024 Regular Session - Authored & Sponsored Legislation (Page 2)

Legislative Session

Primary Sponsor of Legislation

NH

New Hampshire 2024 Regular Session

New Hampshire House Bill HB1524

Introduced
12/11/23  
Refer
12/11/23  
Engrossed
2/22/24  
Refer
2/22/24  
Relative to authorizing parents of special education children to observe in the classroom setting.
NH

New Hampshire 2024 Regular Session

New Hampshire House Bill HB242

Introduced
1/9/23  
Relative to banning PFAS in food packaging.

Co-Sponsor of Legislation

NH

New Hampshire 2024 Regular Session

New Hampshire House Bill HB1649

Introduced
12/15/23  
Refer
12/15/23  
Report Pass
2/12/24  
Report DNP
2/12/24  
Refer
2/22/24  
Report Pass
3/29/24  
Report DNP
3/29/24  
Engrossed
4/16/24  
Refer
4/16/24  
Report Pass
5/8/24  
Report Pass
5/21/24  
Enrolled
7/23/24  
Chaptered
8/6/24  
Relative to prohibiting certain products with intentionally added PFAS and relative to civil actions for PFAS contamination, and relative to settlement of lawsuits against manufacturers of PFAS for impacts to public drinking water systems.
NH

New Hampshire 2024 Regular Session

New Hampshire House Bill HB1707

Introduced
12/19/23  
Refer
12/19/23  
Relative to liability for the cost of PFAS blood testing.
NH

New Hampshire 2024 Regular Session

New Hampshire House Bill HB212

Introduced
1/3/23  
Refer
1/3/23  
Report Pass
2/15/23  
Refer
2/22/23  
Appropriating funding for investigations, testing, and monitoring relative to per- and polyfluoroalkyl substances.
NH

New Hampshire 2024 Regular Session

New Hampshire House Bill HB465

Introduced
1/11/23  
Restricting use of perfluoroalkyl and polyfluoroalkyl substances in certain consumer products.
NH

New Hampshire 2024 Regular Session

New Hampshire House Bill HB614

Introduced
1/12/23  
Refer
1/12/23  
Report Pass
2/16/23  
Refer
2/22/23  
Making an appropriation to the department of health and human services to fund the Merrimack, New Hampshire Kidney Cancer Incidence Phase 3 Feasibility study.